Company: IMNN
Filing Date: 2025-05-19
Form Type: S-1/A
Source: 0001641172-25-011388
Chunk: 31

Company: Imunon, Inc.
Filing Date: 2025-05-19
Form: S-1/A
Chunk 31
---
 the holders of Common Stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock which may be designated and issued in the future.

Our Common Stock is listed on Nasdaq under the symbol “IMNN.”

Transfer Agent and Registrar

The transfer agent and registrar for our Common Stock is Equiniti Trust Company, LLC. Equiniti Trust Company, LLC is located at 6201 15 thAvenue, Brooklyn, NY 11219. Their telephone number is (888) 999-0032.

Preferred Stock

Undesignated Preferred Stock

Pursuant to our Certificate of Incorporation, our board of directors has the authority, without further action by the stockholders (unless such stockholder action is required by applicable law or Nasdaq rules), to designate and issue shares of preferred stock in one or more series, to establish from time to time the number of shares to be included in each such series, to fix the designations, powers (including voting), privileges, preferences and relative participating, optional or other rights, if any, of the shares of each such series and the qualifications, limitations or restrictions thereof and to increase or decrease the number of shares of any such series, but not below the number of shares of such series then outstanding.

We will fix the designations, powers (including voting), privileges, preferences and relative participating, optional or other rights, if any, of the preferred stock of each series, as well as the qualifications, limitations or restrictions thereof, in the certificate of designation relating to that series. The certificate of designation will describe the terms of the series of preferred stock. This description will include:

| ● | the                               
 title and stated value;           |
| ● | the                               
 number of shares we are offering; |

| 13 |

| ● | the                                                                                                                                     
 liquidation preference per share;                                                                                                       |
| ● | the                                                                                                                                     
 purchase price;                                                                                                                         |
| ● | the                                                                                                                                     
 dividend rate, period and payment date and method of calculation for dividends;                                                         |
| ● | whether                                                                                                                                 
 dividends will be cumulative or non-cumulative and, if cumulative, the date from which dividends will accumulate;                       |
| ● | the                                                                                                                                     
 procedures for any auction or remarketing, if any;                                                                                      |
| ● | the                                                                                                                                     
 provisions for a sinking fund, if any;                                                                                                  |
| ● | the                                                                                                                                     
 provisions for redemption or repurchase, if applicable, and any restrictions on our ability to exercise